Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk

Warfarin in haemodialysis patients with atrial fibrillation: what benefit?

(2010) F. Yang et al.   EUROPACE

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

EFFECT OF AGE AND RENAL FUNCTION ON THE RISKS OF STROKE AND MAJOR BLEEDING WITH DABIGATRAN COMPARED TO WARFARIN: AN ANALYSIS FROM THE RE-LY STUDY

(2010) Jeff S. Healey et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy

(2010) Volker Wizemann et al.   KIDNEY INTERNATIONAL

New oral anticoagulant drugs in cardiovascular disease

(2010) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?

(2010) John W. Eikelboom et al.   THROMBOSIS AND HAEMOSTASIS

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation

(2009) Alan S. Go et al.   CIRCULATION

Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with Atrial Fibrillation

(2009) K. E. Chan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation

(2008) Yi Wan et al.  

Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease

(2008) H. Reinecke et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY